Literature DB >> 30454938

Reply.

Hashem B El-Serag1, David Y Graham1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30454938      PMCID： PMC6903693          DOI： 10.1016/j.cgh.2018.08.031

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  6 in total

Review 1.  The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.

Authors:  Carlo A Fallone; Naoki Chiba; Sander Veldhuyzen van Zanten; Lori Fischbach; Javier P Gisbert; Richard H Hunt; Nicola L Jones; Craig Render; Grigorios I Leontiadis; Paul Moayyedi; John K Marshall
Journal:  Gastroenterology       Date:  2016-04-19       Impact factor: 22.682

2.  ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Authors:  William D Chey; Grigorios I Leontiadis; Colin W Howden; Steven F Moss
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

3.  Helicobacter pylori infection and antibiotic resistance: a WHO high priority?

Authors:  Bich N Dang; David Y Graham
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-03       Impact factor: 46.802

4.  Illusions regarding Helicobacter pylori clinical trials and treatment guidelines.

Authors:  David Y Graham
Journal:  Gut       Date:  2017-09-21       Impact factor: 23.059

5.  Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.

Authors:  Hashem B El-Serag; John Y Kao; Fasiha Kanwal; Mark Gilger; Frank LoVecchio; Steven F Moss; Sheila E Crowe; Adam Elfant; Thomas Haas; Ronald J Hapke; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-17       Impact factor: 11.382

Review 6.  Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.

Authors:  Yi-Chia Lee; Tsung-Hsien Chiang; Chu-Kuang Chou; Yu-Kang Tu; Wei-Chih Liao; Ming-Shiang Wu; David Y Graham
Journal:  Gastroenterology       Date:  2016-02-02       Impact factor: 22.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.